Supportive Care Considerations in the Treatment of NHL
This information was originally presented on September 21, 2013, at the NCCN 8th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Apply the key recommendations for supportive care in patients with NHL, including the management of tumor lysis syndrome and prevention/management of viral reactivations
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center
- 0.50 Participation
- 0.43 Nurse
- 0.50 Pharmacist
- 0.50 Physician